Enzo Biochem, Inc.
ENZB · OTC
7/31/2024 | 7/31/2023 | 7/31/2022 | 7/31/2021 | |
|---|---|---|---|---|
| Market Cap | $58,028 | $72,757 | $117,597 | $157,103 |
| - Cash | $52,371 | $82,373 | $21,603 | $13,524 |
| + Debt | $3,509 | $6,998 | $20,587 | $22,676 |
| Enterprise Value | $9,166 | -$2,618 | $116,581 | $166,255 |
| Revenue | $31,907 | $31,061 | $107,071 | $117,731 |
| % Growth | 2.7% | -71% | -9.1% | – |
| Gross Profit | $14,632 | $11,566 | $41,967 | $53,577 |
| % Margin | 45.9% | 37.2% | 39.2% | 45.5% |
| EBITDA | -$8,348 | -$22,340 | -$15,007 | $3,345 |
| % Margin | -26.2% | -71.9% | -14% | 2.8% |
| Net Income | -$26,078 | $20,288 | -$22,578 | $3,425 |
| % Margin | -81.7% | 65.3% | -21.1% | 2.9% |
| EPS Diluted | -0.51 | -1.27 | -0.46 | 0.071 |
| % Growth | 59.8% | -176.1% | -748.8% | – |
| Operating Cash Flow | -$26,259 | -$36,976 | -$16,590 | $387 |
| Capital Expenditures | -$545 | -$2,760 | -$3,472 | -$4,436 |
| Free Cash Flow | -$26,804 | -$39,736 | -$20,062 | -$4,049 |